GeneDx Holdings Corp. 8-K Report: Key Insights on Stock and Warrants Trading

Based on the provided section of the financial report, here are the key insights and information extracted:
- Entity Information:
- Company Name: GeneDx Holdings Corp.
- CIK Number: 0001818331
- IRS Employer Identification Number (EIN): 85-1966622
- Address: 333 Ludlow Street, North Tower, 6th Floor, Stamford, CT 06902
- Phone Number: 888-729-1206
- Filing Information:
- Filing Type: Form 8-K
- Filing Date: January 13, 2025
- SEC File Number: 001-39482
- Securities Information:
- Common Stock:
- Class: Class A common stock
- Par Value: $0.0001 per share
- Trading Symbol: WGS
- Exchange: NASDAQ
- Warrants:
- Type: Warrants to purchase one share of Class A common stock
- Exercise Price: $379.50 per share
- Warrant Symbol: WGSWW
- Exchange: NASDAQ
- Segment Information:
- The filing includes details regarding the common class of stock and warrants as part of the financial reporting.
- Segments:
- Class of Stock: Common Class A member
- Warrant Member
- Reporting Context:
- The report states specific periods, both starting and ending on January 13, 2025, indicating that these figures are for a single reporting date.
Insights:
- GeneDx Holdings Corp. is actively trading its Class A common stock and related warrants on NASDAQ under the symbols WGS and WGSWW, respectively.
- The high exercise price of $379.50 for the warrants suggests a significant premium over the current stock price, which may indicate a strategic approach to raising capital or incentivizing long-term investment.
- This filing is likely a significant event for the company, as Form 8-K is often used to report major events that shareholders should know about.
This summary encapsulates the essential components of the financial report section provided, highlighting the company's trading status and the specifics of its securities.